WO1999036116A1 - Device for inhaling medicament - Google Patents

Device for inhaling medicament Download PDF

Info

Publication number
WO1999036116A1
WO1999036116A1 PCT/NL1999/000028 NL9900028W WO9936116A1 WO 1999036116 A1 WO1999036116 A1 WO 1999036116A1 NL 9900028 W NL9900028 W NL 9900028W WO 9936116 A1 WO9936116 A1 WO 9936116A1
Authority
WO
WIPO (PCT)
Prior art keywords
foregoing
medication
dose
rotatable
cavities
Prior art date
Application number
PCT/NL1999/000028
Other languages
English (en)
French (fr)
Inventor
Wilhelmus Maria Van Gelderen
Alfred James Nijkerk
Johannes Wilhelmus Maria Sanders
Sander Jeroen Sinot
Original Assignee
Pharmachemie B.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmachemie B.V. filed Critical Pharmachemie B.V.
Priority to IL13718699A priority Critical patent/IL137186A0/xx
Priority to AU19860/99A priority patent/AU1986099A/en
Priority to EP99900714A priority patent/EP1047468A1/de
Publication of WO1999036116A1 publication Critical patent/WO1999036116A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0028Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/0045Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0028Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/0045Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters
    • A61M15/0046Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters characterized by the type of carrier
    • A61M15/0048Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters characterized by the type of carrier the dosages being arranged in a plane, e.g. on diskettes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00Special media to be introduced, removed or treated
    • A61M2202/06Solids
    • A61M2202/064Powder
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/21General characteristics of the apparatus insensitive to tilting or inclination, e.g. spill-over prevention
    • A61M2205/215Tilt detection, e.g. for warning or shut-off

Definitions

  • inhaler devices for inhaling medication, for instance for asthma patients, are very common nowadays.
  • multi-dose inhalers wherein one powdered (or liquid) dose at a time is transported from a reservoir to a mixing space, whereafter, after suction, the medication reaches the bronchial tubes of the user via the mouth.
  • Inhaler devices further exist wherein one or more doses arranged in a blister pack are placed in a device, whereafter the medication can be inhaled after piercing of the blister pack. It is also known to inhale from an inhaler device the content of a capsule which must first be pierced or divided.
  • an inhaler device wherein a disc-shaped blister pack is rotated each time and perforated by a pin which can be operated by a coil spring.
  • This construction is relatively complicated and expensive and is not suitable as disposable inhaler device; only the blister pack is discarded.
  • the present invention has for its object to provide a disposable inhaler device which can be manufactured in large numbers at relatively low cost price; the dimensions thereof can remain extremely small, so that the user can readily take along one or more of such inhaler devices and throw them away after use.
  • the present invention provides a device for inhaling medication, comprising:
  • a first housing part provided with one or more cavities in which a dose of a pre-determined quantity of medication can be arranged;
  • first and second housing parts are movable relative to one another between a first position wherein the cavities with powdered medication are closed and a second position in which the interior of one of the cavities is placed in connection with an air path and the medication can be inhaled.
  • the movable part is rotatable, wherein a number of cavities for the medication for dispensing is accommodated in the rotatable part. It is however also conceivable for the first and second housing parts to be mutually slidable.
  • the rotatable part is preferably rotatable in one direction and a clear click is audible and can be clearly felt as soon as a dose is rotated to the dispensing position. If the rotatable part is accidentally revolved too far without a dose being inhaled, this dose is again closed off from the environment with further rotation. Since in the preferred embodiment the device is blocked after the last dose has been rotated into the air path, a dose which has been revolved too far further remains inaccessible .
  • the device is enclosed by a liquid-tight and/or airtight packaging in order to prevent the medication becoming moist (and possibly lumpy) and/or losing its activity over a longer period of time.
  • a liquid-tight and/or airtight packaging in order to prevent the medication becoming moist (and possibly lumpy) and/or losing its activity over a longer period of time.
  • this outer wrapper can be further arranged information relevant to the product and it also serves as guarantee for the user that the device is definitely safe and has not been used before.
  • a number of devices according to the present invention can also be arranged in a blister-type packaging.
  • the number of doses can amount to one, for instance in the case of morphine, but can also amount to four or more, for instance sufficient for use in one week.
  • closing means are for instance provided herein for closing off a dose of medication so that it cannot fall out of the device without being inhaled when this latter is upside down, and/or blocking means for blocking the mutual rotation movement in upside down position of the device.
  • fig.l shows an isometric bottom view of a preferred embodiment of a device according to the present invention
  • fig. 2 shows an isometric top view of the preferred embodiment shown in fig. 1
  • fig. 3 is a top view of a component of the preferred embodiment shown in fig. 1 and 2
  • fig. 4 shows a disassembled view of the device shown in fig. 1 and 2, wherein the component of fig. 3 is filled with medication
  • fig. 5 is a view in cross-section along the line V-V of fig. 2 ; fig.
  • FIG. 6 shows a partly broken-away perspective view of a further preferred embodiment of the device according to the present invention
  • fig. 7A and 7B show respective partly broken- away views of a further preferred embodiment of a device according to the present invention in a first respectively second position
  • fig. 8 is a partly broken-away perspective view of a further preferred embodiment of a device according to the present invention
  • fig. 9 shows a partly broken-away perspective view of a further preferred embodiment according to the present invention
  • fig. 10 is a partly broken-away perspective view of a further preferred embodiment according to the present invention
  • fig. 11 is a partly broken-away perspective view of a further preferred embodiment according to the present invention
  • a device 1 (fig. 1-5) is preferably packed in a packaging 2 which is in any case (water-) vapour-tight but preferably also airtight, such as a blister pack, a foil 3 of which can be pulled off a short time before use.
  • Device 1 further comprises a mouthpiece 4 which is provided on the top side with a raised edge 5 in order to ensure that the device is inserted to the correct distance, but not too far, into the mouth.
  • the device can be arranged in a blister-type packaging in which for instance four or six devices are included, of which one at a time can then be pressed through the blister pack.
  • Mouthpiece 4 is preferably formed integrally with a housing part 10 (see in particular fig. 4) and comprises a central bush 6 with a slightly flexible wall part 7 which is separated from wall part 7 via gaps 32, one of which is visible. Situated on the top side is a suction opening 9 with ribs 11 extending thereover. When the air is sucked in for instance at a minimum quantity of 20 litres per minute, the air moving over the cavity is drawn in and the powder from the cavity is carried along by the airflow. In the shown preferred embodiment the air resistance is moderate, i.e. a user with low sucking power can also draw the powder from the cavity.
  • the component 10 is preferably further provided with markings (4, 3, 2 respectively 1) indicating the number of doses still to be inhaled.
  • a suction opening can also be arranged in the bottom in order to further reduce the air resistance and to prevent the air resistance becoming too great if the user should accidentally place a finger on one of the two suction openings .
  • the part 12 is provided with a protrusion 14 for the counting mechanism, while it is further provided with cavities 16, 17, 18 and 19 for receiving powdered medication preferably poured therein.
  • cavities 16-19 recesses 21, 22, 23, 24 and 25 are arranged for strengthening the structure, saving plastic material and preventing moisture from entering cavities 16-19.
  • a gap 32 is shown in fig. 4 adjacently of flexible wall part 7.
  • housing part 10 is locked in snapping manner on lower housing part 12 such that in practice the device cannot be opened by the user.
  • the device is situated in the neutral position or starting position shown in fig. 2, wherein protrusion 14 indicates that four doses are still available.
  • the lower housing part 12 is rotated, wherein flexible wall part 7 rotates along the protruding wall part 26 and falls between wall parts 26 and 27 with a clicking sound which can also be felt.
  • an air path is left clear over the relevant cavity and the powder is carried out of the cavity into the mouthpiece by the underpressure generated by the airflow.
  • Fig. 5 further shows clearly that the upper part has a substantially conical surface, which connects onto a conical surface on the lower part situated beneath a snap edge .
  • a minimal distance (d) is left clear so as to avoid problems in respect of the tolerances in the applied injection moulding technique; use is preferably made of a high-grade, injection-mouldable plastic which can for instance be re-used for other purposes.
  • the flexible wall part arrives in the end position between the standing end portions of edge parts 29 and 31, in which position the device is blocked against further rotation, the user knows that the inhaler can be discarded, which is indicated by the counting mechanism which no longer points to a number of still available doses.
  • a dosage of medication for some medicines with addition of carrier material (such as lactose) is preferable dispensed in the cavities such that the user feels in mouth and throat cavities that inhalation has taken place.
  • component 44 is provided for the purpose of strengthening the ratchet mechanism with two pawls 47 and 48, of which pawl 48 is partly broken away in fig. 6 and which both fall into the recesses between inclining protrusions 45, 46, four of which are arranged on component 42 in this embodiment with four dosages.
  • the blocking or end stop after inhaling of the final dose then preferably takes place by means of protrusion 49, which also indicates the number of doses still to be used and, after the final dose, falls in a manner not shown into a recess on the outside of component 42 or clamps against the mouthpiece of component 44.
  • a blocking element 51 is arranged in a recess 50 in component 42, which element, in the case of reversal as according to arrow A, will drop due to its own weight into a respective recess 52 in component 44 which has a smaller depth than recess 50 such that rotation is then blocked.
  • the number of recesses in component 44 will correspond to the number of cavities in which medicinal powder is received. It will be apparent that it is possible to suffice with one cavity when the blocking element is centrally arranged in the point of rotation.
  • a valve 61 blocking the airflow is arranged pivotally on a shaft 62, while in the position of valve 61 shown in fig. 7A, wherein the airflow is blocked, the dose of medicine is covered using a slidable valve element 64.
  • valve 61 pivots on shaft 62 and slide valve 64 is displaced in the direction of arrow D, so that dose d is released and can be inhaled.
  • Slide valve 64 displaces for instance under the influence of a spring element, the force of which in the direction of arrow D is checked in closed position of valve 61, for instance using a finger.
  • disc 63 is rotated to the following dose, slide 64 is moved back to the position closing off the following dose .
PCT/NL1999/000028 1998-01-15 1999-01-15 Device for inhaling medicament WO1999036116A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
IL13718699A IL137186A0 (en) 1998-01-15 1999-01-15 Device for inhaling medicament
AU19860/99A AU1986099A (en) 1998-01-15 1999-01-15 Device for inhaling medicament
EP99900714A EP1047468A1 (de) 1998-01-15 1999-01-15 Vorrichtung zum inhalieren von medikamenten

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL1008031 1998-01-15
NL1008031A NL1008031C2 (nl) 1998-01-15 1998-01-15 Inrichting voor het inhaleren van medicament.

Publications (1)

Publication Number Publication Date
WO1999036116A1 true WO1999036116A1 (en) 1999-07-22

Family

ID=19766347

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/NL1999/000028 WO1999036116A1 (en) 1998-01-15 1999-01-15 Device for inhaling medicament

Country Status (6)

Country Link
EP (1) EP1047468A1 (de)
AU (1) AU1986099A (de)
IL (1) IL137186A0 (de)
NL (1) NL1008031C2 (de)
WO (1) WO1999036116A1 (de)
ZA (1) ZA99283B (de)

Cited By (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002000280A3 (en) * 2000-06-23 2002-05-02 Ivax Corp Pre-metered dose magazine for breath-actuated dry powder inhaler
WO2007132217A1 (en) * 2006-05-16 2007-11-22 Hovione Inter Ag A simple inhaler
WO2010042036A1 (en) * 2008-10-08 2010-04-15 Astrazeneca Ab Inhaler with audible indicator means
WO2010042033A1 (en) 2008-10-08 2010-04-15 Astrazeneca Ab Inhalation device and method of dispensing medicament
WO2010063645A1 (de) 2008-12-03 2010-06-10 Boehringer Ingelheim International Gmbh Inhalator
US7763280B2 (en) 2002-11-28 2010-07-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tiotropium containing powder formulation for inhalation
US8151793B2 (en) 2007-12-20 2012-04-10 Astrazeneca Ab Device and method for deaggregating powder
US8236979B2 (en) 2008-07-24 2012-08-07 American Air Liquide, Inc. Methods for synthesis of heteroleptic cyclopentadienyl transition metal precursors
WO2012128692A1 (en) 2011-03-21 2012-09-27 Simplified Solutions Sweden Ab Inhalator for substances in powder form
US8381721B2 (en) 2008-09-26 2013-02-26 Oriel Therapeutics, Inc. Dry powder inhalers with dual piercing members and related devices and methods
US8550071B2 (en) 2008-09-26 2013-10-08 Oriel Therapeutics, Inc. Inhalers with airway disks having discrete airway channels and related disks and methods
US8646446B2 (en) 2008-10-01 2014-02-11 Oriel Therapeutics, Inc. Dry powder inhalers with rotating piercing mechanisms and related devices and methods
US8887722B2 (en) 2008-09-26 2014-11-18 Oriel Therapeutics, Inc. Inhaler mechanisms with radially biased piercers and related methods
US9050427B2 (en) 2008-09-30 2015-06-09 Oriel Therapeutics, Inc. Dry powder inhalers with multi-facet surface deagglomeration chambers and related devices and methods
US9114221B2 (en) 2009-03-10 2015-08-25 Euro-Celtique S.A. Counter
JP2015163276A (ja) * 2009-07-01 2015-09-10 アストラゼネカ・アクチエボラーグAstrazeneca Aktiebolag 粉末を気流に引き込むためのディスペンサーおよび方法
US9179691B2 (en) 2007-12-14 2015-11-10 Aerodesigns, Inc. Delivering aerosolizable food products
USD745660S1 (en) 2010-03-26 2015-12-15 Oriel Therapeutics, Inc. Dry powder inhaler
US9415178B2 (en) 2009-03-10 2016-08-16 Euro-Celtique S.A. Counter
WO2016174393A1 (en) * 2015-04-30 2016-11-03 Hovione Technology Limited Powder compartment for high dosage drug delivery
US9592355B2 (en) 2005-09-09 2017-03-14 Raymond John Bacon Dispenser
US9707360B2 (en) 2004-11-19 2017-07-18 Clinical Designs Limited Substance source

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3565070A (en) * 1969-02-28 1971-02-23 Riker Laboratories Inc Inhalation actuable aerosol dispenser
US4860740A (en) * 1980-10-30 1989-08-29 Riker Laboratories, Inc. Powder inhalation device
DE3823535A1 (de) * 1988-07-12 1990-01-18 Heinrich Prof Dr Ing Reents Vorrichtung zum dosieren von mikrofeinem pulver und tabletten
US5301666A (en) * 1991-12-14 1994-04-12 Asta Medica Aktiengesellschaft Powder inhaler
WO1994014492A2 (en) * 1992-12-18 1994-07-07 Schering Corporation Inhaler for powdered medications
US5372128A (en) * 1993-04-14 1994-12-13 Habley Medical Technology Corporation Fluidizing powder inhaler
US5642727A (en) * 1995-07-25 1997-07-01 David Sarnoff Research Center, Inc. Inhaler apparatus using a tribo-electric charging technique
WO1997025086A2 (en) * 1996-01-03 1997-07-17 Glaxo Group Limited Inhalation device

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5622166A (en) 1995-04-24 1997-04-22 Dura Pharmaceuticals, Inc. Dry powder inhaler delivery system

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3565070A (en) * 1969-02-28 1971-02-23 Riker Laboratories Inc Inhalation actuable aerosol dispenser
US4860740A (en) * 1980-10-30 1989-08-29 Riker Laboratories, Inc. Powder inhalation device
DE3823535A1 (de) * 1988-07-12 1990-01-18 Heinrich Prof Dr Ing Reents Vorrichtung zum dosieren von mikrofeinem pulver und tabletten
US5301666A (en) * 1991-12-14 1994-04-12 Asta Medica Aktiengesellschaft Powder inhaler
WO1994014492A2 (en) * 1992-12-18 1994-07-07 Schering Corporation Inhaler for powdered medications
US5372128A (en) * 1993-04-14 1994-12-13 Habley Medical Technology Corporation Fluidizing powder inhaler
US5642727A (en) * 1995-07-25 1997-07-01 David Sarnoff Research Center, Inc. Inhaler apparatus using a tribo-electric charging technique
WO1997025086A2 (en) * 1996-01-03 1997-07-17 Glaxo Group Limited Inhalation device

Cited By (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2372215A (en) * 2000-06-23 2002-08-21 Norton Healthcare Ltd Pre-metered dose magazine for breath-actuated dry powder inhaler
US6655381B2 (en) 2000-06-23 2003-12-02 Ivax Corporation Pre-metered dose magazine for breath-actuated dry powder inhaler
EP1294420B2 (de) 2000-06-23 2016-08-31 Norton Healthcare Limited Vorabgefülltes dosismagazin für einen atmungsbetätigten trockenpulverinhalator
WO2002000280A3 (en) * 2000-06-23 2002-05-02 Ivax Corp Pre-metered dose magazine for breath-actuated dry powder inhaler
US7763280B2 (en) 2002-11-28 2010-07-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tiotropium containing powder formulation for inhalation
US9707360B2 (en) 2004-11-19 2017-07-18 Clinical Designs Limited Substance source
US9592355B2 (en) 2005-09-09 2017-03-14 Raymond John Bacon Dispenser
US10369307B2 (en) 2005-09-09 2019-08-06 Clinical Designs Limited Dispenser
AU2007251402B2 (en) * 2006-05-16 2009-02-05 Hovione International Ltd A simple inhaler
KR101035885B1 (ko) 2006-05-16 2011-05-20 호비온 인터 아게 간소형 흡입기
US8109267B2 (en) 2006-05-16 2012-02-07 Hovione International Ltd. Simple inhaler
WO2007132217A1 (en) * 2006-05-16 2007-11-22 Hovione Inter Ag A simple inhaler
US9179691B2 (en) 2007-12-14 2015-11-10 Aerodesigns, Inc. Delivering aerosolizable food products
JP2014158950A (ja) * 2007-12-20 2014-09-04 Astrazeneca Ab 粉末854を脱凝集解体する装置ならびに方法
US8151793B2 (en) 2007-12-20 2012-04-10 Astrazeneca Ab Device and method for deaggregating powder
US8578933B2 (en) 2007-12-20 2013-11-12 Astrazeneca Ab Entraining powder in an airflow
US8479729B2 (en) 2007-12-20 2013-07-09 Astrazeneca Ab Device and method for deaggregating powder
US9283337B2 (en) 2007-12-20 2016-03-15 Astrazeneca Ab Dispenser and method for entraining powder in an airflow
US8236979B2 (en) 2008-07-24 2012-08-07 American Air Liquide, Inc. Methods for synthesis of heteroleptic cyclopentadienyl transition metal precursors
US8381721B2 (en) 2008-09-26 2013-02-26 Oriel Therapeutics, Inc. Dry powder inhalers with dual piercing members and related devices and methods
US8550071B2 (en) 2008-09-26 2013-10-08 Oriel Therapeutics, Inc. Inhalers with airway disks having discrete airway channels and related disks and methods
US8887722B2 (en) 2008-09-26 2014-11-18 Oriel Therapeutics, Inc. Inhaler mechanisms with radially biased piercers and related methods
US9597465B2 (en) 2008-09-26 2017-03-21 Oriel Therapeutics, Inc. Methods of operating and fabricating inhalers with airway disks having discrete airway channels
US9795749B2 (en) 2008-09-26 2017-10-24 Oriel Therapeutics, Inc. Dry powder inhalers with dual piercing members and methods of operating same
US8671938B2 (en) 2008-09-26 2014-03-18 Oriel Therapeutics, Inc. Inhalers with airway disks having discrete airway channels and related disks and methods
US8985103B2 (en) 2008-09-26 2015-03-24 Oriel Therapeutics, Inc. Dry powder inhalers with dual piercing members
US10493222B2 (en) 2008-09-26 2019-12-03 Oriel Therapeutics, Inc. Dry powder dose container assemblies and related inhalers
US9050427B2 (en) 2008-09-30 2015-06-09 Oriel Therapeutics, Inc. Dry powder inhalers with multi-facet surface deagglomeration chambers and related devices and methods
US8646446B2 (en) 2008-10-01 2014-02-11 Oriel Therapeutics, Inc. Dry powder inhalers with rotating piercing mechanisms and related devices and methods
EA019293B1 (ru) * 2008-10-08 2014-02-28 Астразенека Аб Ингаляторное устройство и способ раздачи лекарственного средства
AU2009302956B2 (en) * 2008-10-08 2012-09-13 Astrazeneca Ab Inhalation device and method of dispensing medicament
WO2010042036A1 (en) * 2008-10-08 2010-04-15 Astrazeneca Ab Inhaler with audible indicator means
WO2010042033A1 (en) 2008-10-08 2010-04-15 Astrazeneca Ab Inhalation device and method of dispensing medicament
US9095670B2 (en) 2008-10-08 2015-08-04 Astrazeneca Ab Inhalation device and method of dispensing medicament
CN102176939A (zh) * 2008-10-08 2011-09-07 阿斯利康(瑞典)有限公司 带有声音指示器装置的吸入器
AU2009302956B8 (en) * 2008-10-08 2012-09-27 Astrazeneca Ab Inhalation device and method of dispensing medicament
US8919341B2 (en) 2008-12-03 2014-12-30 Boehringer Ingelheim International Gmbh Inhaler
WO2010063645A1 (de) 2008-12-03 2010-06-10 Boehringer Ingelheim International Gmbh Inhalator
JP2012510324A (ja) * 2008-12-03 2012-05-10 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 吸入器
US9114221B2 (en) 2009-03-10 2015-08-25 Euro-Celtique S.A. Counter
US9987441B2 (en) 2009-03-10 2018-06-05 Euro-Celtique S.A. Counter
US9415178B2 (en) 2009-03-10 2016-08-16 Euro-Celtique S.A. Counter
JP2015163276A (ja) * 2009-07-01 2015-09-10 アストラゼネカ・アクチエボラーグAstrazeneca Aktiebolag 粉末を気流に引き込むためのディスペンサーおよび方法
US9211383B2 (en) 2009-07-01 2015-12-15 Astrazeneca Ab Dispenser and method for entraining powder in an airflow
USD745660S1 (en) 2010-03-26 2015-12-15 Oriel Therapeutics, Inc. Dry powder inhaler
WO2012128692A1 (en) 2011-03-21 2012-09-27 Simplified Solutions Sweden Ab Inhalator for substances in powder form
CN103547306A (zh) * 2011-03-21 2014-01-29 简化解决方案瑞典公司 用于粉末形式物质的吸入器
EP2688619A4 (de) * 2011-03-21 2014-10-22 Simplified Solutions Sweden Ab Inhalator für pulverförmige substanzen
US9987440B2 (en) 2011-03-21 2018-06-05 Simplified Solutions Sweden Ab Inhalator for substances in powder form
EP2688619A1 (de) * 2011-03-21 2014-01-29 Simplified Solutions Sweden AB Inhalator für pulverförmige substanzen
JP2014513608A (ja) * 2011-03-21 2014-06-05 シムプリフィード ソリューションズ スウェーデン エービー 粉末形態の物質用の吸入器
WO2016174393A1 (en) * 2015-04-30 2016-11-03 Hovione Technology Limited Powder compartment for high dosage drug delivery
RU2675686C1 (ru) * 2015-04-30 2018-12-21 Ховионе Текнолоджи Лимитед Порошковая камера для доставки больших доз лекарственных средств
US10478572B2 (en) 2015-04-30 2019-11-19 Hovione Technology Ltd. Powder compartment for high dosage drug delivery

Also Published As

Publication number Publication date
EP1047468A1 (de) 2000-11-02
ZA99283B (en) 1999-12-08
NL1008031C2 (nl) 1999-07-21
AU1986099A (en) 1999-08-02
IL137186A0 (en) 2001-07-24

Similar Documents

Publication Publication Date Title
WO1999036116A1 (en) Device for inhaling medicament
US7556035B2 (en) Unit dose dry powder inhaler
JP4754758B2 (ja) 同一側部に空気流れの入口及び出口を備えた薬物容器
AU554502B2 (en) Powder inhalation device
EP0883414B1 (de) Inhaliervorrichtung
US5207217A (en) Multiple single-dose inhaler for medicaments in powder form
KR101585707B1 (ko) 건조분말 흡입기용 회전 카세트 시스템
JP4485069B2 (ja) 吸入装置に関する改良
US5351683A (en) Device for the administration of powdered medicinal substances
CN100569309C (zh) 单元剂量干粉吸入器
US20170106154A1 (en) Dry powder inhaler
AU2001249773A1 (en) Medicament container with same side airflow inlet and outlet and method of use
BR112013000238B1 (pt) Inalador de pó seco
JP2001524363A (ja) 乾燥粉末吸入器
JP4723785B2 (ja) 粉末吸入装置
CN114949483B (zh) 一种干粉吸入器及其制造方法
TWI832021B (zh) 乾粉吸入器及監控器和乾粉吸入器之套件
WO2009102274A1 (en) Inhaler comprising a base having at least one sealed cavity containing medicament
CN115916305A (zh) 多载体药物分配器

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 1999900714

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 137186

Country of ref document: IL

NENP Non-entry into the national phase

Ref country code: KR

WWP Wipo information: published in national office

Ref document number: 1999900714

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWE Wipo information: entry into national phase

Ref document number: 09600457

Country of ref document: US

WWW Wipo information: withdrawn in national office

Ref document number: 1999900714

Country of ref document: EP